Clinical studies recruiting near Aschaffenburg

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Non-interventional, Prospective Study With Benralizumab
Phase N/A · Research Site · AstraZeneca · NCT06422078 REscue Stenting With CREDO® Heal for Recanalisation After Unsuccessful Thrombectomy (RECHRUT)
Phase N/A · Institut für Radiologie und Neuroradiologie, Klinikum Aschaf · Acandis GmbH · NCT05345483 A Study on the Tolerability, Safety and Effectiveness of Asciminib in Patients With Philadelphia Chromosome-positive Chr
Phase N/A · Novartis Investigative Site · Novartis Pharmaceuticals · NCT07549516 Real-World Clinical Experience of Patients With Metastatic Castration-Resistant Prostate Cancer Treated With Olaparib +
Phase N/A · Research Site · AstraZeneca · NCT06380738 A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previ
Phase 3 · Pfizer · NCT07144280 GMALL Registry and Collection of Biomaterial: Prospective Data Collection Regarding Diagnosis, Treatment and Outcome of
Phase N/A · Klinikum Aschaffenburg · Goethe University · NCT02872987 A Real World Effectiveness Study of Pegcetacoplan in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)
Phase N/A · Studienzentrum Aschaffenburg · Swedish Orphan Biovitrum · NCT05776472 Analysis of TPE Treatments With multiFiltratePRO
Phase N/A · Klinikum Aschaffenburg-Alzenau · Fresenius Medical Care Deutschland GmbH · NCT06272084 Study of Cabozantinib in Participants With Neuroendocrine Tumors Who Have Already Received Prior Treatment
Phase N/A · MVZ am Klinikum Aschaffenburg · Ipsen · NCT07314164 Therapy Optimisation for the Treatment of Hairy Cell Leukemia
Phase 2/Phase 3 · Community based hemato-oncology medical office · University of Giessen · NCT02131753 A Study of Trastuzumab DeRuxtecan for Patients With Advanced HER2-pOsitive GaStric or GastroesoPhageal Junction AdEnocar
Phase N/A · MVZ am Klinikum Aschaffenburg · Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company · NCT05993234 Safety and Efficacy of T-DXd vs. CDK4/6i-based ET as First-line Therapy of HR-positive and HER2-low/Ultralow Advanced Br
Phase 2 · MVZ Klinikum Aschaffenburg · MedSIR · NCT06486883 Binimetinib Plus Encorafenib Real Life Investigation of Next Generation Melanoma Treatment
Phase N/A · 8 · Pierre Fabre Pharma GmbH · NCT04045691 Randomized Controlled Trial of Remote Symptoms Monitoring With Resilience PRO Compared to Care As Usual Only
Phase 3 · Resilience · NCT06867705 PROVIDENCE - Prospective Non-interventional Study (NIS) to Examine Patient-reported Outcomes and Real-world Clinical Dat
Phase N/A · Research Site · AstraZeneca · NCT05573893 Evaluating the Effectiveness of Typology-based Coaching on Patients' Therapy Management
NA · Institut fuer Frauengesundheit · NCT07708571 Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PI
Phase 3 · MVZ Klinikum Aschaffenburg · Relay Therapeutics, Inc. · NCT06982521 Digital Dementia Registry Bavaria (digiDEM Bayern): a Multicentre, Prospective, Longitudinal Register Study Including Pe
Phase N/A · Klinikum Aschaffenburg-Alzenau · University of Erlangen-Nürnberg Medical School · NCT07721701 Randomized Trial in Adult de Novo Ph Positive ALL With Chemotherapy, Imatinib or Ponatinib, Blinatumomab and SCT
Phase 2 · Klinikum Aschaffenburg · Goethe University · NCT06061094 Elacestrant + Everolimus in Patients ER+/HER2-, ESR1mut, Advanced Breast Cancer Progressing to ET and CDK4/6i.
Phase 3 · MVZ Klinikum Aschaffenburg · MedSIR · NCT06382948 A Study of Clinical Outcomes in Participants With EGFR Mutated Advanced Non-Small Cell Lung Cancer (NSCLC) in a Real-Wor
Phase N/A · MVZ am Klinikum Aschaffenburg Onkologie · Janssen Research & Development, LLC · NCT07230691 BRAF Inhibitor Encorafenib And Cetuximab Real Life Investigation of Next Generation CRC Treatment
Phase N/A · Medical Car Centre · Pierre Fabre Pharma GmbH · NCT04673955 Clinical Performance of the New Plasma Filter PX2 in TPE Treatments
NA · Klinikum Aschaffenburg-Alzenau · Fresenius Medical Care Deutschland GmbH · NCT06382675 Praegnant Breast Cancer: Early/Advanced/Metastatic
Phase N/A · University Hospital Tuebingen · NCT02338167 Study of the Use of Venetoclax in Participants With Chronic Lymphocytic Leukemia (CLL) Under Real-Life Setting
Phase N/A · MVZ am Klinikum Aschaffenburg Onkologie /ID# 201548 · AbbVie · NCT03342144 A Study to Investigate Effects of Ocrelizumab Treatment on Neurofilament Light Chain (NfL) Levels and Participant Satisf
Phase N/A · Neuropraxis im Stadtpalais Dres. Ulzheimer/Herröder/Wessig G · Hoffmann-La Roche · NCT06780150 Combination of Abemaciclib and Endocrine Therapy in Hormone Receptor Positive HER2 Negative Locally Advanced or Metastat
Phase 4 · Klinikum Aschaffenburg-Alzenau gGmbH · Prof. Wolfgang Janni · NCT05362760 ITP Registry and Accompanying Biospecimen Collection
Phase N/A · MVZ am Klinikum Aschaffenburg · Jena University Hospital · NCT05152238 Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adu
Phase 3 · Pfizer · NCT07222566 Phase III Study of Induction and Consolidation Chemotherapy With Venetoclax in Patients With Newly Diagnosed AML or MDS-
Phase 3 · Klinikum Aschaffenburg-Alzenau gGmbH · University of Ulm · NCT04628026

Look up another city

Look up another condition